Wednesday, May 22, 2013 Last update: 3:03 PM
Company Tech News as it Breaks
Trade Events
bluebird bio
News articles for bluebird bio:
Monday, May 6, 2013
- bluebird bio Appoints Two New Members to Its Board of Directors Wendy Dixon, Ph.D., and David Schenkein, M.D.bluebird bio, a clinical-stage biotechnology company focused on transforming the lives of patients with severe genetic and orphan diseases using gene therapy, today announced that Wendy Dixon, Ph.D., ... read more
Thursday, March 21, 2013
- bluebird bio Announces Global Strategic Collaboration with Celgene to Advance Gene Therapy in Oncologybluebird bio, a privately-held biotechnology company focused on gene therapy, today announced the formation of a broad, global strategic collaboration with Celgene Corporation to discover, develop and ... read more
Thursday, January 3, 2013
- bluebird bio to Present at the 31st Annual J.P. Morgan Healthcare Conferencebluebird bio, a leader in the development of potentially transformative one-time gene therapies for severe genetic diseases, announced today that Nick Leschly, ... read more